No Detail Found!

HER-2 /NEU oncoprotein: A biomarker in human prostate cancer.

Author(s)
Imdad Hussain Department of Pathology, Dow Medical College, Karachi, Pakistan
Syed Qaisar Naqvi Department of Pathology, Dow Medical College, Karachi, Pakistan
Qammar Jamal Pathology Department, Ziauddin Medical University, Karachi, Pakistan
Waheeduz Zaman Tariq Department of Virology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Faizuddin Karachi Medical & Dental College (KMDC), Karachi, Pakistan
Abrar Shaikh SGM Medical College Sukkur, Pakistan
Aziz Merjan Gomal Medical College, Dera Ismail Khan, Pakistan
Abstract
Obiective: To determine the frequencies of HER-2/neu overexpression in prostate adenocarcinoma. Design: A retrospective study of 50 patients suffering from prostate adenocarcinoma. Setting: BMSI, Jinnah Post Graduate Medical Centre Karachi 1999-2001. Subjects: Fifty patients between the ages of 50-80 years were selected during period 1990-2001 having prostate carcinoma. Results: Maximum numbers of tumour among total cases were in age group ranging from 51-60 years i.e.13 tumours (26% of total cases). Frequency of HER/2neu expression was found to be 12%. All the positive cases were poorly differentiated with Gleason score 8-10. Conclusions: HER-2/neu overexpression was present in 12% of prostatic adenocarcinoma cases. Specific therapeutic targeting of these neoplasms may be accomplished with (Herceptin), which may reveal a new treatment option.
Publication Details
Page(s) 61-64
DOI DOI not available
Published Journal: Pakistan Journal of Pathology, Volume: 16, Issue: 2, Year: 2005

Request the full text from PASTIC

0

Citations

0

Downloads

52

Views